Larson Financial Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Larson Financial Group's URGN Position: Q3 2026 in Review
Larson Financial Group held its UroGen Pharma (URGN) position steady in Q3 2026 at 485 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.
Larson Financial Group first reported a position in URGN in Q3 2025 and has held it in 5 quarters since. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Larson Financial Group held 485 shares of UroGen Pharma worth $19.7K as of Q3 2026.
- Larson Financial Group left its UroGen Pharma share count unchanged in Q3 2026.
- UroGen Pharma made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2123 holding.
- Larson Financial Group first reported a position in UroGen Pharma in Q3 2025 and has held it in 5 quarters since.
- 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.